Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy

By  

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 121-128

Bentham Science Publishers

Access to resources Recommend Favorite

Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

By Milano Amalia   De Rosa Vincenzo   Iaffaioli Rosario Vincenzo   Caponigro Francesco  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 6, 2007-06 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite

Anti-epidermal growth factor receptor drugs in cancer therapy

By Tortora Giampaolo   Ciardiello Fortunato  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 755-768

Informa Healthcare

Access to resources Recommend Favorite

Delay of treatment change after objective progression on first-line erlotinib in epidermal growth factor receptor-mutant lung cancer

By Lo Peter C.   Dahlberg Suzanne E.   Nishino Mizuki   Johnson Bruce E.   Sequist Lecia V.   Jackman David M.   Jänne Pasi A.   Oxnard Geoffrey R.  

Cancer, Vol. 121, Iss. 15, 2015-08 ,pp. : 2570-2577

Blackwell Publishing

Access to resources Recommend Favorite